Antares Vision, a provider of serialization-based pharmaceutical track and trace systems and inspection equipment, has introduced ATSFour, an enterprise-level serialization software aimed at fighting counterfeiting in the pharmaceutical industry.
The new ATSFour integrates Antares Tracking System, and offers a comprehensive, scalable system that allows ‘the widest connection capability available for any traceability framework’, according to Antares Vision. The software manages the serialization data flow connecting production plants, CMOs, third-party logistics and authorities, and manages high volumes of data through an innovative data storage system.
ATSFour creates a unique point of connection enabling interface with healthcare agencies, CMOs and other brand owners operating with a variety of software and hardware systems. ATSFour offers two different installation options: on a cloud platform, and also on-premises in the local server infrastructure of the pharmaceutical company. Moreover, ATSFour can be configured on an entirely dedicated cloud space that is not shared with other companies.
A number of companies have already chosen to implement the ATSFour system, including Recordati, Salf, Sit, Fine Foods, Marlex, biomo pharma, Renata, Faes, Saneca, Sovereign, Adhex, Sifi, Dms, Sirton, Promed and Falorni. Last year, The European Commission has awarded Antares Vision a grant for the development of new technology for the inspection of lyophilised injectables.
Antares Vision was founded in 2007 and is based in Travagliato, Italy. Company designs, manufactures, and installs inspection systems for the pharmaceutical sector. The company’s products include blister filling control, print quality control, package integrity control, total layout control, total capsule inspection. The company was founded in 2007 and is based in Travagliato, Italy.